Histopathological grading affects survival in patients with IDH-mutant grade II and grade III diffuse gliomas
Enrico Franceschi, Alicia Tosoni, Stefania Bartolini, Santino Minichillo, Antonella Mura, Sofia Asioli, Daniela Bartolini, Marina Gardiman, Marco Gessi, Claudio Ghimenton, Felice Giangaspero, Giovanni Lanza, Gianluca Marucci, Mariangela Novello, Enrico Maria Silini, Elena Zunarelli, Alexandro Paccapelo, Alba A. Brandes
Topics & Concepts
MedicineGrading (engineering)Internal medicineHazard ratioIsocitrate dehydrogenaseGastroenterologyIDH1Confidence intervalBiopsyGliomaRadiation therapyOncologyPathologyMutationBiologyCancer researchGeneEnzymeBiochemistryEcologyGlioma Diagnosis and TreatmentMeningioma and schwannoma managementNeuroblastoma Research and Treatments